E-ISSN: 1308-5263
Turk J Hematol. 2017; 34(2): 197-199 | DOI: 10.4274/tjh.2016.0409
2Tepecik Training and Research Hospital, Genetic Diagnostic Center, İzmir, Turkey
3Tepecik Training and Research Hospital, Clinic of Hematology, İzmir, Turkey
Keywords: Cytogenetic, Chronic myeloid leukemia, Molecular hematology, Life-quality, Dasatinib, Nilotinib
2Tepecik Training and Research Hospital, Genetic Diagnostic Center, İzmir, Turkey
3Tepecik Training and Research Hospital, Clinic of Hematology, İzmir, Turkey
Anahtar Kelimeler: Sitogenetik, Kronik miyeloid lösemi, Moleküler hematoloji, Yaşam kalitesi, Dasatinib, Nilotinib
Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30
Mehmet Can Uğur1, Yaşar Bekir Kutbay2, Özge Özer Kaya2, Cengiz Ceylan31Tepecik Training and Research Hospital, Clinic of Internal Medicine, İzmir, Turkey2Tepecik Training and Research Hospital, Genetic Diagnostic Center, İzmir, Turkey
3Tepecik Training and Research Hospital, Clinic of Hematology, İzmir, Turkey
Keywords: Cytogenetic, Chronic myeloid leukemia, Molecular hematology, Life-quality, Dasatinib, Nilotinib
Kronik Miyeloid Lösemili Hastaların Yaşam Kalitesinin EORTC QLQ-C30 Anketi Kullanılarak Değerlendirilmesi
Mehmet Can Uğur1, Yaşar Bekir Kutbay2, Özge Özer Kaya2, Cengiz Ceylan31Tepecik Training and Research Hospital, Clinic of Internal Medicine, İzmir, Turkey2Tepecik Training and Research Hospital, Genetic Diagnostic Center, İzmir, Turkey
3Tepecik Training and Research Hospital, Clinic of Hematology, İzmir, Turkey
Anahtar Kelimeler: Sitogenetik, Kronik miyeloid lösemi, Moleküler hematoloji, Yaşam kalitesi, Dasatinib, Nilotinib
Corresponding Author: Mehmet Can Uğur, Türkiye
Manuscript Language: English
Manuscript Language: English
Copyright © 2025 Turkish Journal of Hematology